Nombre del Modulo |
1.2.1.3 Libro científico |
Titulo |
When can you start? http://myvidster.fun/ myvidster video "This deal is a strong strategic fit for AstraZeneca,reinforcing both our focus on oncology as a core therapy areaand Japan as one of our key growth drivers," said Marc Dunoyer,executive vice pres |
Subtitulo |
When can you start? http://myvidster.fun/ myvidster video "This deal is a strong strategic fit for AstraZeneca,reinforcing both our focus on oncology as a core therapy areaand Japan as one of our key growth drivers," said Marc Dunoyer,executive vice pres |
Colección |
When can you start? http://myvidster.fun/ myvidster video "This deal is a strong strategic fit for AstraZeneca,reinforcing both our focus on oncology as a core therapy areaand Japan as one of our key growth drivers," said Marc Dunoyer,executive vice pres |
Número de Páginas |
When can you start? http://myvidster.fun/ myvidster video "This deal is a strong strategic fit for AstraZeneca,reinforcing both our focus on oncology as a core therapy areaand Japan as one of our key growth drivers," said Marc Dunoyer,executive vice pres |
Edición |
When can you start? http://myvidster.fun/ myvidster video "This deal is a strong strategic fit for AstraZeneca,reinforcing both our focus on oncology as a core therapy areaand Japan as one of our key growth drivers," said Marc Dunoyer,executive vice pres |
ISBN |
When can you start? http://myvidster.fun/ myvidster video "This deal is a strong strategic fit for AstraZeneca,reinforcing both our focus on oncology as a core therapy areaand Japan as one of our key growth drivers," said Marc Dunoyer,executive vice pres |
Pais |
When can you start? http://myvidster.fun/ myvidster video "This deal is a strong strategic fit for AstraZeneca,reinforcing both our focus on oncology as a core therapy areaand Japan as one of our key growth drivers," said Marc Dunoyer,executive vice pres |
Idioma |
When can you start? http://myvidster.fun/ myvidster video "This deal is a strong strategic fit for AstraZeneca,reinforcing both our focus on oncology as a core therapy areaand Japan as one of our key growth drivers," said Marc Dunoyer,executive vice pres |
Editorial |
When can you start? http://myvidster.fun/ myvidster video "This deal is a strong strategic fit for AstraZeneca,reinforcing both our focus on oncology as a core therapy areaand Japan as one of our key growth drivers," said Marc Dunoyer,executive vice pres |
Tiraje |
When can you start? http://myvidster.fun/ myvidster video "This deal is a strong strategic fit for AstraZeneca,reinforcing both our focus on oncology as a core therapy areaand Japan as one of our key growth drivers," said Marc Dunoyer,executive vice pres |
Fecha de Aceptación |
0000-00-00 |
Fecha de Publicación |
0000-00-00 |
Coautores |
When can you start? http://myvidster.fun/ myvidster video "This deal is a strong strategic fit for AstraZeneca,reinforcing both our focus on oncology as a core therapy areaand Japan as one of our key growth drivers," said Marc Dunoyer,executive vice pres |
Año de la Actividad |
2011 |
Observaciones |
When can you start? http://myvidster.fun/ myvidster video "This deal is a strong strategic fit for AstraZeneca,reinforcing both our focus on oncology as a core therapy areaand Japan as one of our key growth drivers," said Marc Dunoyer,executive vice pres |
Proyecto de Investigacion Asignado |
|